The company has seen significant revenue growth, with over 300% year-over-year increase. They have partnerships with China’s Ping An Ventures, a major Healthcare AI company, and thousands of investors.
Revenue Amount
$30,000,000
Organizations Involved
China’s Ping An Ventures, thousands of investors
Founders
Not provided
Company Description
20/20 GeneSystems is a digital diagnostics company focused on reducing cancer mortality through early detection. They have expanded their test menu to include Covid-19 testing solutions. The company leverages real-world data and machine learning to improve the accuracy of clinical lab testing, with plans to expand to heart disease and other chronic conditions.